-
Part 2 | Session 3 5 Trials That Will Change My Practice With Dr Bernardo Cortese
-
Part 3 | Session 1 5Y Outcomes From the PARTNER 3 Low-Risk Trial
-
Part 3 | Session 3 Four-Year Outcomes from the EVOLUT Low Risk Trial
-
Part 3 | Session 5 WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR
-
Part 1 | Session 1 View from the Thoraxcenter: TCT 23 Late-breaking Science Preview
-
Part 1 | Session 2 View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
-
Part 2 | Session 1 5 Trials That Will Change My Practice With Dr Kendra Grubb
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice.
Trials covered in detail include:
Agent IDE
ALIGN-AR
PARTNER 3
EVOLUT Low-Risk
TRISCEND
Recorded remotely from Jeddah, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent
Stay up-to-date with our regular review series, View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2023 edition they provide a short analysis of the most pertinent data from the late-breaking science presentations.
Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data.
More from this programme
Part 1
View from the Thoraxcenter
Part 2
Highlights
Part 3
Interviews
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.
Academic History
Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…
Comments